Transparency crucial to addressing issues in pharmaceutical events

Transparency in discussions is crucial to navigating around compliance issues and complex codes when organising medical events.

This was recently claimed at a masterclass session at ‘Navigating Compliance Waters’, an event hosted by Kenes Education which discussed issues faced by organisers looking to put on events in the field. According to, this formed part of an interactive conference at a conference space in London, led by a number of experts in associations, sponsorship, industry and compliance.

Delegates heard of the frequent changes made to accreditation criteria and industry compliance in relation to two areas – continuing medical education (CME) and continuing professional development (CPD).

Cited by, Jane Landles, secretary to the Prescription Medicines Code of Practice Authority (PMCPA) – which administers Codes of Practice for the British Pharmaceutical Industry – urged companies to be transparent in their contributions to future events. Ms Landles added that she’d sooner spend time keeping the industry out of trouble, rather than digging it out of it.

Addressing the audience, she stated: “It’s important you know about the codes that the industry has. There is no point in a conference organiser putting together an offering that the industry can’t accept.”

In response, Nicky Simpson, an associate director congress at pharmaceutical company Astellas Pharma Europe, claimed his own firm were fully aware that codes of practice will change over time and that Astellas was already planning for the future.

“We will look to engage earlier with the congress organiser,” he commented. “We should be transparent and open in all our dealings.”